1.725 USD
-0.17 (-9.21%)
1.7 USD
-0.03 (-1.45%)
ChartMill assigns a Buy % Consensus number of 88% to EIGR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 91.8. This target is 5221.74% above the current price.
EIGR was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about EIGR.
In the previous month the buy percentage consensus was at a similar level.
EIGR was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-29 | Citigroup | Maintains | Buy -> Buy |
| 2023-06-30 | Baird | Maintains | Outperform -> Outperform |
| 2022-09-07 | BTIG | Maintains | Buy |
| 2021-08-09 | Citigroup | Maintains | Buy |
EIGER BIOPHARMACEUTICALS INC / EIGR FAQ
What do analysts expect the price target to be for EIGER BIOPHARMACEUTICALS INC (EIGR)?
8 analysts have analysed EIGR and the average price target is 91.8 USD. This implies a price increase of 5221.74% is expected in the next year compared to the current price of 1.725.
What is the consensus rating for EIGR stock?
The consensus rating for EIGER BIOPHARMACEUTICALS INC (EIGR) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover EIGER BIOPHARMACEUTICALS INC (EIGR) stock?
The number of analysts covering EIGER BIOPHARMACEUTICALS INC (EIGR) is 8.